Filter by Topic
- People (18) Apply People filter
- Experiments (9) Apply Experiments filter
- Reproduction (7) Apply Reproduction filter
- Publications (4) Apply Publications filter
- Theories (3) Apply Theories filter
- Ethics (2) Apply Ethics filter
- Legal (2) Apply Legal filter
- Organizations (2) Apply Organizations filter
- Technologies (2) Apply Technologies filter
- Disorders (1) Apply Disorders filter
- Organisms (1) Apply Organisms filter
- Outreach (1) Apply Outreach filter
- Processes (1) Apply Processes filter
- Reproductive Health Arizona (1) Apply Reproductive Health Arizona filter
Filter by Format
The First Successful Cloning of a Gaur (2000), by Advanced Cell Technology
The first successful cloning of a gaur in 2000 by Advanced Cell Technology involved the cells of two animals: an egg cell from a domestic cow and a skin cell from a gaur. The researchers extracted the egg cell from the ovary of the domestic cow and the skin cell from the skin of the gaur. First, the researchers performed nuclear transplantation on the egg cell of the cow, during which they removed the nucleus of the egg cell. The mitochondria of the egg cell remained intact inside the cell.
Subject: Experiments, Organisms, Reproduction
The First Successful Cloning of a Gaur (2000), by Advanced Cell Technology
Advanced Cell Technology (ACT), a stem cell biotechnology company in Worcester, Massachusetts, showed the potential for cloning to contribute to conservation efforts. In 2000 ACT researchers in the United States cloned a gaur (Bos gaurus), an Asian ox with a then declining wild population. The researchers used cryopreserved gaur skin cells combined with an embryo of a domestic cow (Bos taurus). A domestic cow also served as the surrogate for the developing gaur clone.
Christopher Polge and Lionel Edward Aston Rowson’s Experiments on the Freezing of Bull Spermatozoa (1950–1952)
In 1952, researchers Christopher Polge and Lionel Edward Aston Rowson, who worked at the Animal Research Center in Cambridge, England, detailed several experiments on protocols for freezing bull semen for use in the artificial insemination of cows. Freezing sperm extends the life of a viable sperm sample and allows it to be used at later times, such as in artificial insemination. The researchers examined the effects of freezing conditions on bull sperm and how well they produce fertilized embryos once thawed.
Robert Lanza (1956- )
During the twentieth and twenty-first centuries, Robert Paul Lanza studied embryonic stem cells, tissues,
and endangered species as chief scientific officer of Advanced Cell
Technology, Incorporated in Worcester, Massachusetts. Lanza's team cloned
the endangered species of gaur Bos gaurus.
Although the gaur did not survive long, Lanza successfully cloned
another cow-like creature, called the banteng
javanicus). Lanza also worked on cloning human embryos
to harvest stem cells, which could be used to treat dieases. While
Ernest John Christopher Polge (1926-2006)
Twentieth-century researcher Ernest John Christopher Polge studied the reproductive processes of livestock and determined a method to successfully freeze, thaw, and utilize viable sperm cells to produce offspring in animals. In 1949, Polge identified glycerol as a cryoprotectant, or a medium that enables cells to freeze without damaging their cellular components or functions. Several years later, Polge used glycerol in a freezing process called vitrification, which enabled him to freeze poultry sperm, thaw that sperm, and use it to fertilize vertebrate embryos.
Robert Geoffrey Edwards's Study of in vitro Mammalian Oocyte Maturation, 1960 to 1965
In a series of experiments between 1960 and 1965, Robert Geoffrey Edwards discovered how to make mammalian egg cells, or oocytes, mature outside of a female's body. Edwards, working at several research institutions in the UK during this period, studied in vitro fertilization (IVF) methods. He measured the conditions and timings for in vitro (out of the body) maturation of oocytes from diverse mammals including mice, rats, hamsters, pigs, cows, sheep, and rhesus monkeys, as well as humans.
Subject: Experiments, Reproduction
Frank Rattray Lillie's Study of Freemartins (1914-1920)
Frank Rattray Lillie's research on freemartins from 1914 to 1920 in the US led to the theory that hormones partly caused for sex differentiation in mammals. Although sometimes applied to sheep, goats, and pigs, the term freemartin most often refers to a sterile cow that has external female genitalia and internal male gonads and was born with a normal male twin.
"Formation of Genetically Mosaic Mouse Embryos and Early Development of Lethal (t12/t12)-Normal Mosaics" (1964), by Beatrice Mintz
The paper "Formation of Genetically Mosaic Mouse Embryos and Early Development of Lethal (t12/t12)-Normal Mosaics," by Beatrice Mintz, describes a technique to fuse two mouse embryos into a single embryo. This work was published in the Journal of Experimental Zoology in 1964. When two embryos are correctly joined before the 32-cell stage, the embryo will develop normally and exhibit a mosaic pattern of cells as an adult.
Leonardo da Vinci's Embryological Drawings of the Fetus
Leonardo da Vinci's embryological drawings of the fetus in the womb and his accompanying observational annotations are found in the third volume of his private notebooks. The drawings of Leonardo's embryological studies were conducted between the years 1510-1512 and were drawn with black and red chalk with some pen and ink wash on paper. These groundbreaking illustrations of the fetus reveal his advanced understanding of human development and demonstrate his role in the vanguard of embryology during the Renaissance.
Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. (ACT) is a biotechnology company that uses stem cell technology to develop novel therapies in the field of regenerative medicine. Formed in 1994, ACT grew from a small agricultural cloning research facility located in Worcester, Massachusetts, into a multi-locational corporation involved in using both human embryonic stem cells (hESC) and human adult stem cells as well as animal cells for therapeutic innovations.
Subject: Organizations, Reproduction
Interspecies SCNT-derived Humanesque Blastocysts
Since the 1950s, scientists have developed interspecies blastocysts in laboratory settings, but not until the 1990s did proposals emerge to engineer interspecies blastocysts that contained human genetic or cellular material. Even if these embryos were not permitted to mature to fetal stages, their ethical and political status became debated within nations attempting to use them for research.
"Sheep Cloned by Nuclear Transfer from a Cultured Cell Line" (1996), by Keith Campbell, Jim McWhir, William Ritchie, and Ian Wilmut
In 1995 and 1996, researchers at the Roslin Institute in Edinburgh, Scotland, cloned mammals for the first time. Keith Campbell, Jim McWhir, William Ritchie, and Ian Wilmut cloned two sheep, Megan and Morag, using sheep embryo cells. The experiments indicated how to reprogram nuclei from differentiated cells to produce live offspring, and that a single population of differentiated cells could produce multiple offspring. They reported their results in the article 'Sheep Cloned by Nuclear Transfer from a Cultured Cell Line' in March 1996.
Ian Wilmut (1944- )
British embryologist Sir Ian Wilmut, best known for his work in the field of animal genetic engineering and the successful cloning of sheep, was born 7 July 1944 in Hampton Lucy, England. The family later moved to Scarborough, in the north of the country, to allow his father to accept a teaching position. There Wilmut met Gordon Whalley, head of the biology department at Scarborough High School for Boys, which Wilmut attended.
De Formato Foetu (c. 1600), by Girolamo Fabrici
The embryological treatise De formato foetu (The Formed Fetus) was written by anatomist and embryologist Girolamo Fabrici. There is no conclusive evidence regarding the first date of publication and what is listed on many copies ranges from 1600-1620, with speculation that the dates were altered by hand. Most forms of the book are dated 1600 and were issued by Franciscus Bolzetta who sold many copies in Venice and whose name appears on the engraved title-page. There is also verification of the book being printed in Padua by Laurentius Pasquatus in 1604.
Embryonic Sex Differentiation and Sex Hormones (1947), by Carl R. Moore
In 1947, Carl Richard Moore, a researcher at the University of Chicago, in Chicago, Illinois, wrote Embryonic Sex Differentiation and Sex Hormones, which was published in the same year as a first-edition monograph. In the book, Moore argues that regulation of sex differentiation in mammals is not controlled by sex hormones secreted by embryonic sex organs (gonads), but is controlled by non-hormonal genetic factors.
Subject: Publications, Experiments
"Ethical Issues in Human Stem Cell Research: Executive Summary" (1999), by the US National Bioethics Advisory Commission
Ethical Issues in Human Stem Cell Research: Executive Summary was published in September 1999 by The US National Bioethics Advisory Commission in response to a national debate about whether or not the US federal government should fund embryonic stem cell research. Ethical Issues in Human Stem Cell Research recommended policy to US President William Clinton's administration, which advocated for federal spending on the use of stem research on stem cells that came from embryos left over from in vitro fertilization (IVF) fertility treatments.
Girolamo Fabrici (1537-1619)
Girolamo Fabrici, known as Hieronymus Fabricius in Latin, was given the surname Aquapendente from the city where he was born, near Orvieto, Italy. Born in 1533, Fabrici was the eldest son of a respected noble family, whose coat of arms appears as an illustration in the title page of Fabrici's book on embryology, De formato foetu. Little is known of Fabrici's parents. His father is recorded as Fabricio, and Fabrici is said to have been named for his paternal grandfather.
Karl Freiherr von Rokitansky (1804–1878)
During the nineteenth century, Karl Freiherr von Rokitansky conducted research on the causes of disease by performing approximately 30,000 autopsies, a practice that many people opposed at the time. Rokitansky performed his research in pathology, or the study of disease, and morbid anatomy, or the study of dead bodies, in Vienna, then part of the Austrian Empire and later part of Austria.
The Roslin Institute (1993- )
The Roslin Institute was established in 1993 in the village of Roslin, Scotland, as an independent research center by the Biotechnology and Biological Sciences Research Council (BBSRC), and as of 2014 is part of the University of Edinburgh in Edinburgh, Scotland. Researchers at the Roslin Institute cloned the Dolly the sheep in 1996. According to the Roslin Institute, Dolly was the first mammal to develop into an adult from the transfer of the nucleus of an adult sheep cell into an ovum with the nucleus removed.
"Viable Offspring Derived from Fetal and Adult Mammalian Cells" (1997), by Ian Wilmut et al.
In the 1990s, Ian Wilmut, Jim McWhir, and Keith Campbell performed experiments while working at the Roslin Institute in Roslin, Scotland. Wilmut, McWhir, and Campbell collaborated with Angelica Schnieke and Alex J. Kind at PPL Therapeutics in Roslin, a company researching cloning and genetic manipulation for livestock. Their experiments resulted in several sheep being born in July 1996, one of which was a sheep named Dolly born 5 July 1996.
Pierre Budin (1846-1907)
Pierre Constant Budin worked in France to improve the lives of newborns and their mothers during the late nineteenth century. Budin stressed the importance of proper nutrition in infants and educated new mothers on breastfeeding and infant care. Budin established infant care facilities and created a nutritional check-up system for infants. Budin helped design early artificial nipples, breast pumps, and incubators for premature newborns. He also began the practice of consulting with new mothers after they gave birth, redefining the roles of obstetricians.
Subject: People, Reproduction
South Korea's Bioethics and Biosafety Act (2005)
The South Korean government passed the Bioethics and Biosafety Act, known henceforth as the Bioethics Act, in 2003 and it took effect in 2005. South Korea's Ministry of Health and Welfare proposed the law to the South Korean National Assembly to allow the progress of biotechnology and life sciences research in South Korea while protecting human research subjects with practices such as informed consent. The Bioethics Act establishes a National Bioethics Committee in Seoul, South Korea.
Rosalyn Sussman Yalow (1921-2011)
Rosalyn Sussman Yalow co-developed the radioimmunoassay (RIA), a method used to measure minute biological compounds that cause immune systems to produce antibodies. Yalow and research partner Solomon A. Berson developed the RIA in the early 1950s at the Bronx Veterans Administration (VA) Hospital, in New York City, New York. Yalow and Berson's methods expanded scientific research, particularly in the medical field, and contributed to medical diagnostics. For this achievement, Yalow received the Nobel Prize in Physiology or Medicine in 1977.
Neonatal Respiratory Distress Syndrome and Its Treatment with Artificial Surfactant
Neonatal respiratory distress syndrome, previously called hyaline membrane disease, is a respiratory disease affecting premature newborns. Neonatal respiratory distress syndrome involves shallow breathing, pauses between breaths that last a few seconds, or apnea, and a bluish tinge to the infant’s skin. The syndrome occurs when microscopic sacs called alveoli in infant lungs do not produce surfactant, a liquid that coats the inside of the lungs and helps them inflate during breathing.
George Nicholas Papanicolaou (1883–1962)
George Nicholas Papanicolaou developed the Pap test in the United States during the twentieth century. The Pap test is a diagnostic procedure used to test for cervical cancer in women. Papanicolaou’s work helped improve the reproductive health of women by providing an effective means of identifying precancerous cells and improving the likelihood of early treatment and survival of cervical cancer.
Subject: People, Reproduction